80 likes | 259 Views
Managing VC investments 13 th February 2003 David Ward MTI Partners (www.mtifirms.com). MTI’s History. Founded in 1983 with first fund (MTI) of £9m Second fund MTI Ventures raised 1990 - £15M, and third fund MTI3 raised £30m in 1997
E N D
Managing VC investments13th February 2003David WardMTI Partners(www.mtifirms.com)
MTI’s History • Founded in 1983 with first fund (MTI) of £9m • Second fund MTI Ventures raised 1990 - £15M, and third fund MTI3 raised £30m in 1997 • All now fully invested with MTI (2.7X) and MTIV realised in whole or majority part • MTI3 - 65% cash returned, balance of portfolio still strong • The current fund - MTI4 had a final closing in Jan 01 • £ 105m, currently ~ 40% invested or committed
MTI’s Principal Features - I • Substantial operational CEO experience of MTI executive team • Extensive participation in management of investee companies by MTI executive team • Focus on UK early stage technology - investing series A or B with £1m - £5m; expecting to double commitment during life of investment • Invests in companies that have unique and protectable IPR in the general technology sector including: • IT software & hardware • Comms software & hardware • Materials Science • Industrial products • Biotech (e.g. medical devices)
MTI’s Principal Features - II • Long standing and stable executive team - currently 7 investment professionals + 2 support professionals • “Best of Breed” performance in high technology early stage venture capital • UK centric, based in Watford and London • Limited Partners are long term investors, mostly Institutional Pension funds (MTI funds are 10 year duration)
Example Investment Focus - I • Software • Security – Armoursoft & Phocis • NMS – Chevin & Viewgate • Data mining – IntelliQ • Image handling – iBase • Document management - Formscape • Communications • Hardware – Citel • Services – Message Pad • Fabless chip - DCT
Example Investment Focus - II • Materials Science • Carbon fibre – ACG • Display technology – STL • Specialist inks - Sherwood • Life Science • Drug discovery – Hunter Fleming • Healthcare software – ex investee
Thank you!David WardMTI PartnersWeb: www.mtifirms.comEmail: dward@mtifirms.com